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ABSTRACT 
 
 
 Endoplasmic reticulum (ER) stress is caused by the accumulation of misfolded proteins 
in the ER.  IRE1, an ER localized transmembrane protein kinase, is a sensor of unfolded proteins 
and plays an important role in regulating the cellular rescue response to ER stress.  We have 
engineered FV2E-IRE1β, a drug controlled receptor that exploits the IRE1 cell rescue pathway.  
Addition of the drug AP20187 induces stress-uncoupled activation of FV2E IRE1 and causes 
IRE1 signaling.   Our results indicate that the use of this system has utility in regulating the 
cytoprotective IRE1-ERAD pathway independently of other ER stress-induced signals, such as 
proapototic JNK signaling. 
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BACKGROUND 
 
 
ER Stress and the Unfolded Protein Response 
The Endoplasmic Reticulum (ER) is the cellular organelle where newly synthesized 
proteins obtain their uniquely folded conformations.  As a result of managing the multitude of 
enzymes and other proteins produced in the body, the ER’s inter-luminal protein concentration 
may reach up to 100 mg/ml (Horwich et al, 2002).  Subsequently, these proteins must be 
effectively packaged and folded in order for normal cellular function to occur or else the cell 
could be eliminated through apoptosis via a self-induced caspase cascade. In order to manage 
these significant protein concentrations, the ER employs a system of chaperone molecules which 
aids in protein folding and handling (Patil and Walter, 2001).  At the transcriptional level, the ER 
employs a system known as the unfolded protein response (UPR) which increases the natural 
folding capacity of the ER by upregulation of target genes, as well as decreasing the translational 
burden in the ER by translational attenuation (Urano et al, 2000a).   
 
The ERAD System 
It is also possible for misfolded proteins to move across the ER lumen and be destroyed 
by the ubiquitin proteosome pathway.  This system is known as endoplasmic reticulum 
associated protein degradation (ERAD) and often enables the cell to be “rescued” from deadly 
ER stress.  The ubiquitin proteasome pathway is a multi-step process that begins with the initial 
activation of the protein “ubiquitin” by a Ubiquitin activating enzyme known as E1.  The 
activation occurs when ATP hydrolysis is coupled with the genesis of an E1-ubiquitin conjugate 
formed by a thiolester bond to the C-terminal glycine residue on ubiquitin (Pickart, 2000).   
Immediately following this linkage, the activated ubiquitin molecule is transferred to a ubiquitin 
conjugating enzyme (E2).  The ubiquitin-E2 conjugate is only an intermediate step that aides in 
attaching the ubiquitin to the substrate via a ubiquitin protein ligase, or an (E3).  The role of the 
E3 is to specifically recruit the substrate, for example a misfolded protein, and attach the 
ubiquitin via its C-terminal glycine to the target’s free lysl e-amino group.  These three steps will 
occur repeatedly on the same protein until the target acquires a “ubiquitin tail.” (Vierstra, 2003).      
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Currently, five different E3 types have been recognized and classified based on their 
subunit composition and chemical mechanisms.  These groups are classified as follows: HECT, 
Ring/U-box, SCF, VBC-Cul2, and APC.  All five E3 ligase classes demonstrate similarity in that 
they all form an arched scaffold that participates in recruitment of the E2-ubiquitin product and 
the subsequent transfer of ubiquitin to the substrate. In order to assure specificity in 
ubiquitination of targets, there are usually a great number of E3 components in every cell 
(Vierstra, 2003). 
Once target proteins acquire a ubiquitin tail, they become targets for destruction in an 
ATP dependent manner via the 26 S proteasome system.  The 26 S proteasome consists of a 20S 
core protease and a 19S regulatory particle.  The proteasome’s specificity is controlled by the 
19S subunit which recognizes and processes poly-ubiquitinated substrates.  Once recognized, the 
19S particle also unfolds, deubiquitinates, and ushers the target into the 20S core protease for 
imminent destruction (Vierstra, 2003). 
 
HRD1: A Novel Component of the ERAD System 
With regard to endoplasmic reticulum stress, this ERAD system is very important as it 
decreases the cellular stress load by degrading unwanted and misfolded proteins.  Of particular 
importance is a novel ER resident E3 ubiquitin ligase called HMG Co-A reductase degradation 1 
(HRD1).  This E3 ligase is a member of the RING family of E3 ligases since it posses a 
RING/H2 domain.  This RING/H2 domain is located in the cytoplasm while the rest of the 
protein resides in the ER.  The RING/H2 domain of HRD1 conveys in vitro Ubiquitination 
activity in the presence of the E2 Ubiquitin conjugating enzyme UBC7 (Kikkert et al, 2004). 
 
HRD1 Protects Cells from ER Stress 
Unpublished recent studies in our lab using the Akita diabetes model mouse have 
demonstrated the importance of the HRD1 system in promoting cellular survival.  The Akita 
mouse is a C57/B6 mouse possessing a heterozygous mutation in the Insulin 2 gene 
(Ins2WT/C96Y).  The mutation occurs when tyrosine is substituted for Cysteine as the 96th amino 
acid in the insulin 2 protein.  This mutation is detrimental to the function of the Insulin 2 protein 
since Cysteine is important for forming the disulfide bonds common to many folded proteins.  
Thus, the result of the Ins2WT/C96Y mutation is a protein that is misfolded.  Consequently, it has 
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been demonstrated that the mouse’s resultant diabetes is a direct effect of ER Stress caused by 
misfolded proteins in the pancreatic β-cells of Akita mice.  The subsequent stress produced by 
this misfolded insulin eventually kills pancreatic β-cells in Akita mice leading to diabetes.   
In considering the important role of Hrd1 in rescuing cells from ER stress through ERAD 
activation we have explored the role of HRD1 in Akita mice.  Preliminary data from real time 
PCR (Figure 1A) and westerns (Figure 1B) conducted on these mice demonstrates that HRD1 
mRNA and protein production are upregulated in Akita mice in comparison to control mice 
(Figure 1B).  Additionally, HRD1 upregulation has also been shown to protect the β-cells of 
Akita mice from apoptosis through ERAD activation.  
 
IRE1, PERK, and ATF6: Central Components of the UPR  
These results suggest that enhancement of ERAD in cells undergoing stress may increase 
cellular survival.  In order to effectively enhance the ERAD response, discovery and control of a 
central upstream regulator of this process is the most important factor.  The discovery of the 
transmembrane protein inositol-requiring 1 (IRE1) as a sensor of unfolded proteins, as well as an 
activator of the UPR was a critical development leading to the creation of a cell rescue system 
based on ERAD (Yoshida et al, 2003).  IRE1 comes in both an α and a β form, where IREα is 
localized in the pancreas and IRE1β is localized in the gut (Urano et al, 2000a).  Apart from their 
different locations, their structures and functions are nearly identical.  In wild type cells, IRE1 
activation enhances HRD1 activity but in IRE1 α-/- cells HRD1 activity is negligible (Figure 
1B).  This indicates that the IRE1 is a critical component in the ERAD system.   
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Figure 1.  Relative Expression Levels of HRD1 mRNA.   
A: Upon treatment of wild type murine cells with tunicamycin followed by real time PCR  
analysis, we found that the E3 ubiquitin ligase HRD1 is highly upregulated.  The 
upregulation of HRD in wild type cells demonstrates its role in managing the increased 
stress load in the cell.  When IRE1α -/- cells were treated with tunicamycin, however, 
a negligible stress-related HRD1 response was observed, indicating that HRD1 expression is linked to IRE1 
activation.  B: Measuring HRD1 levels in the islets of Akita diabetes mice demonstrates that HRD1 levels are highly 
upregulated in order to deal with large amounts of misfolded insulin.  SEL1L and BiP, two other components in ER 
stressmanagement are also upregulated (data, courtesy of the Urano lab) 
 
 
Because of its role as a sensor of unfolded proteins, Ire1 is implicated to be a major part 
of the cell stress cycle.  Though the stress cycle is a very complex system, it is regulated by three 
different sensors.  Ire1 is a transmembrane protein localized within the outer wall of the ER and 
is only one part of the cell’s tripartite system for stress management.  The two other components 
of the ER stress pathway include PKR-like ER kinase (PERK) and activating transcription factor 
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6 (ATF6) (Harding et al, 1999; Yoshida et al, 1998; Yoshida et al, 2000).  In utilizing one, or a 
combination of these three components, the cell is able to protect itself from a good deal of both 
normal and abnormal physiological stresses (Figure 2A). 
 
Figure 2 Three Systems in the Endoplasmic Reticulum That are Essential in the Unfolded Protein Response.   
A: The endoplasmic reticulum has three ways to deal with unfolded proteins.  First, activation of  the ER resident 
transmembrane kinase PERK initiates general translational attenuation and upregulation of target UPR genes.  
Second, ATF6 activation initiates protein degradation as well as upregulation of UPR target genes  Third, the 
activation of IRE1 causes both cell rescue and cell death through XBP-1 mRNA splicing resulting in XBP-1 
transcription factor production.  B:  Because of IRE1’s important role in the ER stress response, harnessing its cell 
rescue capability through XBP-1 while bypassing its cell death function through Caspase-12 and ASK-1 is an 
effective way to decrease cell death.  
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              ATF6 comes in two forms, ATF6α and ATF6β, both of which are ER resident 
transmembrane proteins containing a bZIP domain.  Upon activation of the UPR due to ER 
stress, both forms of ATF6 are cleaved by site-1 and site-2 proteases.  Following cleavage, their 
bZIP domains are transported to the nucleus where they bind to ER stress response elements 
(ERSE) (Wang et al, 2000; Yoshida et al, 2000).  The ERSEs are cis-acting elements containing 
the consensus sequence (5’)CCAAT-N9-CCACG(3’).  With the binding of a transcription factor 
to ERSEs comes upregulation of chaperone production and activation of other UPR genes (Haze 
et al, 1999; Yoshida et al, 1998). 
Another method that the cell employs to deal with stress is to stop general protein 
translation.  Activation of PERK causes phosphorylation of the α subunit of eukaryotic 
translation factor 2 (eIF2α). Phosphorylation of eIF2α transforms eIF2 into an inhibitor of its 
guanine nucleotide exchange factor eIF2B thus effectively stopping translation (Dever, 2002; 
Kaufman 2002).  While the apparent benefit of this phosphorylation is a reduced protein load on 
the cell, UPR genes are also upregulated since one-third of them require eIF2α phosphorylation 
for activation (Scheuner et al, 2001). 
 
IRE1 Regulates the Only Pathway Conserved Among All Eukaryotes     
Though PERK and ATF6 are important to the cell’s ability to handle ER stress, our 
research focuses mainly on IRE1; because of its more diverse role in the UPR by initiation of 
ERAD as well as cell death in more severe cases.  Additionally, IRE1 regulates the only pathway 
conserved among all eukaryotes.  IRE1 is composed of an N-luminal domain (NLD), 
transmembrane domain, Kinase domain, and an RNase domain.   It has been demonstrated that 
the NLD plays a critical role in the effective activation of IRE1 (Liu et al, 2003).  The chaperone 
protein BiP also plays an important role in the UPR.  As a chaperone protein, BiP binds to 
misfolded and aggregated proteins and aides in their management.  Because of its function, BiP 
is bound to IRE1’s N-luminal domain in normal non-stress conditions, thus stabilizing the 
receptor (Marcu et al, 2002).  In the presence of unfolded proteins, however, BiP is released from 
the NLD and attaches to unfolded or misfolded protein to aide in effectively managing the threat 
to the cell.  
In normal cells, release of BiP from the NLD of IRE1 results in its receptor dimerization 
and trans-autophosphorylation signaling transition into the active state.  Upon activation, the 
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RNase domain of IRE1 splices a 26 bp segment of X-box binding protein 1 (XBP-1) mRNA.  By 
splicing this 26 bp segment out of XBP-1, a frameshift is created.  The result of this frameshift is 
the highly active transcription factor XBP-1, which enters the nucleus and leads to up-regulation 
of the UPR genes (Calfon et al, 2002; Urano et al, 2002).  According to recent research, the three 
receptors, PERK, ATF6 and IRE1 work in a time dependent manner.  Since ATF6 activation 
occurs before XBP-1 production, ATF6 causes only refolding of misfolded proteins.  Yet upon 
XBP-1 production, both refolding and the ERAD response occur as a response the more serious 
cases of protein misfolding.    
The action of IRE1 follows a much different path when the most severe cases of ER 
stress are experienced within the cell.  Unlike the previously mentioned cases, where a 
manageable protein load is encountered resulting in IRE1 augmented cell rescue, severe stress 
actually causes IRE1 mediated apoptosis.  This apoptotic mechanism occurs when the normal 
rescue pathway is overridden by burgeoning ER stress.  In this case, IRE1 recruits TNF- 
Receptor Associated Factor 2 (TRAF-2).  This in turn causes activation of apoptosis signaling 
kinase 1 (ASK-1).  Activation of ASK-1 leads to apoptosis through induction of c-Jun N-
terminal protein kinase (JNK) and caspase dependent apoptosis (Leppa and Bohmann, 1999; 
Nishitoh, 2002; Urano et al 2000). 
It is hypothesized that cell death caused by ER stress is mediated by caspases, a family of 
cysteine proteases that are effectors of apoptosis.  In cases of ER stress induced apoptosis, 
Caspase 12 has been implicated as a major component.  Caspase 12 is an ER localized caspase 
activated solely under conditions of ER stress such as challenge with tunicamycin, an inhibitor of 
N-linked glycosylation.  In support of this finding, Nakagawa et al. report that upon tunicamycin 
treatment of renal epithelial cells from wild type and caspase-12 -/- mice, severe damage occurs 
only in wild type cells (Nakagawa et al., 2000).  Since a negligible amount of damage occurs in 
caspase 12 -/- mice, the authors postulate that caspase 12 must mediate cell death via apoptosis.  
Activation of the caspase-related death pathway occurs when TRAF2 is initially recruited by 
Ire1.  In non-stress conditions TRAF2 is bound to procaspase-12 but upon TRAF2 recruitment 
procaspase-12 gathers at the ER triggering its cleavage and subsequent activation (Yoneda et al, 
2001).    
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PROJECT PURPOSE 
 
FV2E-IRE1β: A Drug Inducible System that Activates XBP-1 Splicing   
Based on the aforementioned information, we postulate that the key to mitigating ER 
induced apoptosis is to harness and control the IRE1-ERAD/XBP1 pathway independent of ER-
stress.  Our aim is to override the natural tendency towards apoptosis by allowing the cell to deal 
with very high amounts of stress without effecting TRAF2 induction (Figure 2B).  To mitigate 
this ER stress related apoptotic response, we postulate that small molecule regulated 
dimerization of an engineered IRE1 homolog would prevent the cell’s stress regulatory pathway 
from being overridden.  This could be accomplished by the creation of an engineered construct 
of IRE1 that could be used to rescue the cells from imminent death under stress conditions by 
enhancing the UPR.  The strategy that we have devised to selectively induce dimerization of 
IRE1 involves the use of the ARGENT regulated homodimerization kit from Ariad 
pharmaceuticals        (www.ariad.com/regulationkits).  The homodimerization kit, supplied by 
the company includes a plasmid (PC4M-FV2E) containing two homodimerization domains called 
FKBP (FV) domains.  The FKBP domains can be cut out of the plasmid and inserted into any 
transmembrane protein using recombinant DNA methods.  Once constructed, a receptor bearing 
an FKBP domain can dimerize to an adjacent FKBP domain when treated with the 
homodimerization drug AP20187, an extremely efficient third generation ligand suitable for in 
vivo use (Figure 3).  Using a small molecule dimerization system ensures safe, accurate, and 
precise receptor regulation without interfering with endogenous receptors.   
In order to make our construct, the two homodimerization domains were cut out of the 
plasmid using simple restriction digestion.  The resulting digested product was then subjected to 
a series of modifications resulting in a final modified construct of the beta form of Ire1: FV2E-
IRE1β.  In order to assure that no background XBP-1 activity was present the construct was 
introduced into Ire1 knockout fibroblast cell lines, using a retroviral vector.  Since there is 
naturally no XBP-1 splicing in these knockout cell lines, they can be treated with AP20187 and 
the efficacy of dimerization tested by monitoring the XBP-1 splicing levels.   
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Figure 3.  Utilizing the IRE1 Signaling Pathway to Rescue Cells From Apoptosis. 
A:  The ER resident receptor IRE1 is a sensor of unfolded protein and consists of an N-luminal domain (NLD), 
transmembrane domain (TM), kinase domain and an RNase domain.  Under non-stress conditions, the chaperone 
protein BiP is attached to IRE1’s NLD.  Under stress, however, BiP is released from IRE1 effecting dimerization 
and either splicing of XBP-1 mRNA or activation of JNK.  B: In order to rescue cells from death, a new form of 
IRE1 was created in this project by ligating two “FV” homodimerization domains at the 3’ end of the NLD.  Upon 
treatment with the homodimerization drug AP20187, the XBP-1 signaling pathway can be activated without 
activating the JNK death pathway. 
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Mutations in the Kinase Domain of IRE1 Often Cause Unnatural Effects 
Recently, Papa et al reported that in various mutant forms of IRE1, kinase activity could 
be bypassed using an ATP competitive drug 1-tert-butyl-3-naphthalen-1-ylmethyl-1H-pyrazole 
[3, 4-d] pyrimidi-4-ylemine (1NM-PP1).  Point mutations were created in the kinase domain that 
successfully weakened, in varying degrees, the kinase activity of IRE1 and consequently its 
function as an activator of the UPR. These mutations also created an active site pocket 
sensitizing the mutant IRE1 to 1NM-PP1.  Based upon data from similar experiments in other 
kinases, treatment with the “new” preferred kinase substrate 1NM-PP1 should have effectively 
nullified any remaining kinase activity (Papa et al, 2003).     
Upon 1NM-PP1 treatment of IRE1 kinase dead mutants, however, the expected results 
were not observed.  Contrary to their hypothesis, 1NM-PP1 treatment of kinase dead mutants 
actually restored even the most crippled kinases to 80% activity (RNA splicing ability) in 
comparison to wild type IRE1.  Thus, creation of these 1NM-PP1 sensitized mutants bypasses 
the normal kinase activity and effectively uncouples the kinase and RNase functions of IRE1; 
activating the UPR apart from a stress signal.  The reason for this “stress-free” activation is not 
completely clear but explorations into the 1NM-PP1 mechanism developed the theory that either 
ATP or ADP may be IRE1’s natural substrate.  If this is so, then IRE1 may sense the intricate 
ADP/ATP balance within the cell switching on the UPR when cellular nutrients are low based 
upon the amount of specific adenosine nucleotides within the cell (Schuit et al, 1999).  Based 
upon this research and because we were using a modified form of IRE1 as well, we tested the 
sensitivity of FV2E-IRE1 to varying levels of ATP as well as combinations of ATP and 
AP20187.   
The function of the IRE1 receptor is very important in the clinical realm since it plays an 
important role in enhancement of the ER-associated protein degradation system or ERAD. 
Adapting the FV2E-IRE1β system to perhaps rescue beta cells could potentially facilitate a more 
effective way to control certain forms of diabetes.  With enhanced survivability of beta cells in 
stressed conditions, the patient’s remaining beta cells would be allowed to regain their normal 
cycle of neogenesis and replication.  This in turn would create a level of beta cells sufficient to 
maintain normal insulin production as well as facilitation of euglycemia. 
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METHODS 
 
 
 
Isolation of FV2E and Ligation into pCRIITOPO Vector. 
 In order to create a construct “FV2E-Ire1β,” it was necessary to isolate the FV2E 
fragment from the vector, pC4M-Fv2E (see figure 4A), provided by Ariad pharmaceuticals 
(Cambridge, Ma).  The plasmid contains two FV’ domains, hence the designation of the 
dimerization domain as FV2E, an amino terminal myristoylation signal, and a carboxyl-terminal 
epitope tag flank the 600 bp FV2E fragment.  The fragment is also designed with an amino acid 
wobble in one of the FV segments in order to decrease recombination when using retroviral 
vectors.   The plasmid pC4M-Fv2E was then amplified using PCR primers FV1S ( 5’-
AAAGCTTCTAGAGGCGTCCAAGTC-3’) and FV2AS ( 5’-
CTGCTAGCGTTTCCAGTTTTAGAAG-3’).  The annealing temperature was 57oC for 30 
seconds, with a 68oC extension cycle for 40 seconds.  The program was set to repeat for twenty 
cycles.  The PCR primers added a HindIII (5’) overhang and a NheI (3’) overhang to the FV2E 
fragment.  After the PCR, the resulting plasmid was purified using phenol chloroform extraction 
followed by ethanol precipitation, and reconstituted with 10 µl of TE.  This fragment was then 
ligated into pCRIITOPO using 2 µl of PCR sample, 1 µl of MgCl2 NaCl, and 1 µl of TOPO 
vector (Figure 4A).  After a 30-minute room temperature incubation, the ligation product was 
transformed into TOP10 bacteria for overnight incubation.  Since pCRIITOPO carries the Lac-Z 
marker, we were able to select the colonies positive for the insert using blue-white colony 
selection.  After overnight culture, the resulting plasmid was purified using a Qiagen mini-prep 
kit.  The isolate was reconstituted with 50 µl of TE and then restricted for two hours with HindIII 
and NheI.  This fragment was subjected to agarose gel electrophoresis on a 1.2% gel and the 600 
bp band isolated using a Qiagen gel purification kit.   
 
 
Creation of an FV2E-IRE1β Construct.  
 A tube of mIreβ in pBS-SK (26?37) was obtained, courtesy of David Ron at NYU, and 
restricted with 1 µl of NheI and HindIII (Figure 4B).  This restriction removed a fragment of 46 
bp from the 3’ end of the N-luminal domain adjacent to the transmembrane domain.  This small 
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fragment removal should be insignificant enough that no dimerization interference results from 
NLD distortion.  Initially, ligation using T4 DNA ligase was conducted with 11.5 µl of FV2E 
insert and 1 µl of mIre1β-pBS-SK at room temperature for thirty minutes.  Prior to ligation, a 
comparison of the intensity of the Ire1β versus the Fv2E fragments was conducted by running 5 
µl of each on a 1% agarose gel.  Transformation of the ligation product into DH5α was carried 
out using 7.5 µl of ligation product.  The ligation was unsuccessful.  The purity of FV2E-
PCRIITOPO was assayed using sequencing and restriction.  The fragment and vector were found 
to be satisfactory.  Subsequent ligations were conducted using different ratios of Fv2E to Ire1β in 
the following order: 11.5:1, 1:20, 1:9, 0.3:10, 0.5:12, and 0.8:11.7.  Due to the unsuccessful 
ligations, Ire1β was grown on an ampicillin resistant plate and new colonies were grown 
overnight in order to provide a fresh source of plasmid.  The resulting plasmid, purified using the 
Qiagen miniprep kit, was cut with HindIII and NheI, and purified using phenol chloroform 
extraction and ethanol precipitation.  New ligation concentrations were used; 15:1, 15:0.5, 
10:0.5, these ligations were carried out at 16oC in the thermal cycler overnight.  The ligation 
product was then transformed into DH5α.  The results of colony PCR showed that the only ratio 
that produced colonies was 15:1. Results of sequencing showed that the construct was complete 
and satisfactory except for a mis-sense mutation in a codon for proline.  Fortunately, this 
mutation resulted in no effects since it did not change the amino acid produced.   
 
Insertion of FV2E-IRE1β into pcDNA3.   
In order to express the engineered construct in mammalian cells, it was necessary to 
ligate it into the mammalian expression vector pcDNA3 (Figure 4C).  The vector pcDNA3 
includes a CMV promoter as well as ampicillin and neomycin resistance markers.  Restriction 
enzymes chosen to cut the construct out of pBS-SK were EcoRI and XhoI.  It was originally 
thought that these enzymes were unique to both the insert and the vector.  Yet, upon independent 
restriction tests with each enzyme and target, it was discovered that there is an XhoI site located 
in the Fv’ domain of the construct.  These sites were unique in the vector plasmid, pcDNA3 
yielding an isolable 5.3 kb fragment.  Thus, before ligation, Fv2E-Ire1β underwent complete 
digestion with EcoRI, phenol chloroform precipitation, and then partial digestion with XhoI.  
Following these steps, the 3.5 kb fragment of Fv2EIre1β was isolated.  As in all previous 
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ligations, relative ratios of insert and vector were checked prior to the ligation. In the previous 
ligation of FV2E into Ire1βpBS-SK the molecular mass of Ire1β was considerably greater than 
that of FV2E.  In the FV2EIre1β-pcDNA3 ligation, the molecular masses of insert and vector are 
similar, making this ligation particularly difficult.  With this in mind, many different ratios for 
ligation were experimented with.  All ligation products were transformed into DH5α high 
transformation efficiency bacteria.  The following ligation ratios of insert to vector were 
attempted; 14:2, 15:1 (both multiple times with newly isolated insert and vector), 10:0.5.  Upon 
ligation with ratio of 10:0.5, 20 colonies were observed and a colony PCR was conducted.  No 
insert was detected, probably a result of the vector self ligating.  This most likely resulted 
because the fragment was not isolated from the agarose gel but purified using chloroform phenol 
extraction.  New ligations were also tried with ratio of 18:0.5 resulting in one positive clone.  
After large-scale culture, a midi-prep was conducted using the Qiagen midi prep kit.  Sequencing 
conducted with T7-2 primers showed that the sequence had ligated into the plasmid backwards.  
More ligations, with new material proved to give the same backwards ligation effect in all 
clones, a result of recombination during cloning. 
 
Insertion of Fv2EIRE1β into pcDNA3.1/hygro 
Since the previous ligations produced unsatisfactory results, a new mammalian 
expression vector, pcDNA3.1/hygro was chosen (Figure 4C).  This vector is similar to pcDNA3, 
but instead of neomycin resistance, it caries a hygromycin resistance marker.  Two unique sites 
in both insert and vector, NotI and KpnI, were chosen for restriction.  Ligation using a ratio of 
15:1 was conducted and transformed into DH5α yielding multiple colonies.  Upon sequencing, 
however, the construct was still ligated in the plasmid backwards.  Because of this frequent 
tendency to ligate itself in the wrong direction we decided to use a retroviral vector to express 
the construct in fibroblasts (Figure 4D). 
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Figure 4.  Construction of FV2EIRE1β.    
A: Two “FV” dimerization domains were obtained from the plasmid pC4M-Fv2E by using PCR primers that added 
a 5’ HindIII site and a 3’ NheI site.  The resulting amplified FV2E domain was then ligated into PCRIITOPO and 
was purified after amplification in bacteria.  The plasmid FV2E-PCRIITOPO was then restricted with NheI and 
HindIII to release the FV2E domain.  B: The FV2E domain was then ligated into IRE1β in pBluescript SK (pBS-
SK) and amplified. C: Ligation and amplification yielded the construct FV2E-IRE1β which was then removed from 
pBS-SK using EcoRI (5’) and XhoI (3’) sites.  Ligations into both pcDNA3 and pcDNA3.1/hygro, using NotI (5’) 
and KpnI (3’), were unsuccessful due to the complicated nature of the construction.  D: Because these ligations were 
not successful, a VSV-G retrovirus was created and was used to successfully infect fibroblast cells.      
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Transfection Methods and Protein Detection 
In order to transfect the construct into cells, it was necessary to test different methods of 
transfection with Ire1βpBS-SK.  Two different transfection methods were used to introduce the 
plasmid into mammalian cells.  The first involved using the Fugene transfection reagent provided 
by Roche.  In this method, a six well plate of 293-T cells was created.  Three wells were controls 
and three were transfected.  To initiate transfection, 9.5 µl of Fugene transfection reagent was 
added to 300 µl of serum free media in the center of a round bottom tube.  Next, 2.5 µl of Ire1β 
was added to the mixture and then incubated for thirty minutes at room temperature.  After this 
time, the solution was added drop-wise over the cells.  After thirty-six hours, the product was 
collected and protein was isolated.  The purified protein was then quantified using a set of 
standard samples to generate a standard curve.  Next, 20 µg of protein was run on a 7% 
Polyacrylamide-agarose gel for approximately 50 minutes.  After electrophoresis, the 
electrophoresed product was transferred to a nylon membrane using 100 volts for 60 minutes on 
ice.  Incubation with α-IRE1β antibody and then α-rabbit HRP antibody and standard western 
blot tests were negative for protein expression.   
In light of the failed transfection using Fugene, we decided to use the Calcium Phosphate 
method to transfect another six well plate of 293T cells with Ire1β.  A solution of plasmid DNA, 
water and 2M CaCl2 was created and added to 2X HEPES.  This solution was allowed to 
incubate for five minutes at room temperature and then added drop-wise over the cells.  The 
resulting protein was isolated using Immunoprecipitation, but otherwise the same protocol as 
above.  This time, however, the results were positive for transfection.  
 
Creation of a Retroviral Vector for Transfer of FV2E-IRE1β into Fibroblasts and MIN6 
Cells 
In order to create an adequate amount of virus particles for infection we first plated 2x106   
293T cells into two plates for future use as a “virus factory.”  During the time the cells were 
multiplying, the plasmids pBabe Puro and FV2E-IRE1βpBS-SK were cut with EcoR1 and Sal1 
(Xho1).  The two fragments (FV2E Ire1 and pBabe Puro) were then ligated overnight to produce 
the construct FV2E-IRE1β-pBabe Puro which was then transformed into STBL2 bacteria and 
isolated using a Qiagen midiprep kit.  Using the CaCl2 protocol, the 293T cells were transfected 
with the following components for retrovirus assembly: 0.4 µg pCMVtatHIV, 1.5 µg, 3 µg pJK3 
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pL-VSV-G, and 4.5 µg FV2E-IRE1β-pBabe Puro.  Before application to the cells, water was 
added up to 876 µl and then mixed with 124 µl of 2 M CaCl2.  After it was thoroughly mixed, 1 
mL of 2X Hepes was added to the mixture and the final solution was added to the cells drop 
wise.  The cells were kept away from light at all times so as not to destroy the virus.   
 
Collection of the FV2E-Ire1β-pBabe Puro Retrovirus and Infection into a Fibroblast Cell 
Line.  The cells produced above were allowed to grow overnight and the media was changed the 
following morning. Note: In order to assure proper lab safety technique, all cells were 
manipulated under a properly ventilated hood and all media and equipment used was 
bleached to prevent contamination/infection.  New media was added and the following day, 5 
mL of media was collected and placed in a foil wrapped tube.  New media was added to the 
plates and the procedure was repeated the following day.  The 293T cells were then bleached and 
discarded.  The viral media collection from the two days was pooled and then filtered through a 
0.4 µm filter.  The filtered media containing the virus was then added dropwise over two plates 
containing fibroblast cells.   
 
Creation of a Stable Cell Line Expressing FV2E-Ire1β.   
Infected fibroblast cells were allowed to grow overnight and on the following day, the 
media was changed and treated with 2.5 µl of puromycin to select the fibroblasts bearing the 
construct and expression vector.  Twelve colonies were picked one week later and allowed to 
grow in 24 well plates and then transferred to several individual plates.  Puromycin selection was 
carried out each time the media was changed. In order to develop a stable MIN6 cell line 
expressing FV2E- Ire1β, we used an identical cell culture technique as listed above for fibroblast 
cells but instead added the virus to MIN6 cells and used 2.0 µl of puromycin for selection. 
 
Collection of Nuclear and Cytoplasmic Protein Extracts 
Because isolation of both nuclear and cytoplasmic extracts is critical to development of 
this receptor, we used a combined isolation method for cells used in protein detection.  Plates 
were first washed twice with cold PBS and then plates were placed on ice and 1 mL of cold PBS 
was added to the plates.  These plates were scraped then the cells/PBS was transferred to 1.7 mL 
tubes and the tubes were spun (at 4oC) at 3,000 rpm for 5 minutes to pellet the cells.  The 
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supernatant was poured off and then the pellet resuspended with 500 µl of harvest buffer (10mM 
HEPES, 50 mM NaCl, 0.5 M sucrose, 0.1mM EDTA, 0.5% 100X triton plus proteinase 
inhibitors).  After adding harvest buffer, the cells were incubated for 5 minutes on ice and then 
spun at 1,000 rpm in a swinging bucket rotor in order to pellet the nuclei.  The supernatant was 
transferred to new tubes and spun for 14,000 rpm for 15 minutes to isolate and further purify the 
cytoplasmic extract.  The cytoplasmic extract was then placed in new tubes and stored at -80oC.  
The pellet from the 1,000 rpm centrifugation was then washed in 500 µl buffer “A” (10mM 
HEPES pH 7.9, 10 mM KCL, 0.1mM EDTA, 0.1mM EGTA plus proteinase inhibitors) and spun 
for 5 minutes.  After removing and discarding the supernatant, the pellet was resuspended in 50 
µl of buffer C (10 mM HEPES pH 7.9, 500 mM NaCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% 
IGEPAL (NP40).  The resuspended pellet was vortexed for 15 minutes at medium to high speed 
to break up the pellet.  For final isolation of the nuclear extract, the tubes were spun for 10 
minutes at 14,000 rpm and the supernatant transferred to new tubes and frozen at -80oC.    
 
Antibodies and Protein Detection   
Detection of FV2E-Ire1β.  In order to be sure that FV2E-IRE1β was in fact expressed in 
transfected fibroblast cells, we collected cytoplasmic protein extract from transfected cells and 
analyzed the result using western blot analysis.  To assay for the presence of the insert we used 
α-IRE1β antibody in a 1:3,000 concentration.  Since this antibody was raised against the 
transmembrane domain of IRE1β it is also effective for FV2E-IRE1β detection since the 
transmembrane domains are identical.  For a secondary antibody we used α−rabbit polyclonal 
HRP tagged antibody in a 1:3,000 concentration. 
 
Detection of XBP-1 Protein and mRNA.  XBP-1 mRNA produces a protein 
transcriptional activator that is easily detected using western blot analysis.  To detect XBP-1 
protein, nuclear extract was collected and α-XBP1 antibody was used in a 1:3,000 dilution as a 
primary antibody.  As the secondary antibody we used α-rabbit HRP, in the same dilution.  In 
order to assay for the presence and activity of XBP-1 mRNA, RNA was collected from cells and 
cDNA was created from these RNA’s.  From these cDNA’s we used real time PCR methods as 
described below to explore the characteristics of XBP-1 transcription.                  
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Detection of GRP-78.  Since the chaperone molecule GRP-78/BiP is attached to 
inactivated IRE-1 detecting high levels of GRP-78 in the cytoplasmic extract indicates 
activation.  As a primary antibody, α-GRP78 antibody was used in a 1:5,000 concentration.  
Rabbit polyclonal antibody with an HRP tag was used as a secondary antibody.   
 
Detection of HRD1.  As  previously mentioned, the E3 ubiquitin ligase HRD1 is a major 
factor in the ERAD response and thus it’s detection in the cytoplasmic isolate indicates the 
ERAD response is active.  In order to detect the protein, α-HRD1 antibody was used in a 1:1,000 
concentration.  The secondary antibody, α-rabbit HRP, was used in a 1:3,000 concentration. 
 
Detection of JNK.  In order to be sure that the construct does not cause cell death, we 
tested selected nuclear isolates for phosphorylated JNK apoptosis kinase using α−JNK antibody 
in a 1:3,000 concentration.  The secondary antibody was α−rabbit polyclonal HRP tagged 
antibody. 
 
Detection of Caspase-12.  As a secondary indicator of cell death we also observed the 
activation of Caspase-12 using a 1:3,000 concentration of α-Caspase 12 antibody and α−rabbit 
polyclonal HRP tagged antibody as a secondary antibody. 
 
Detection of Actin.  In order to be sure that western blot results were not flawed due to 
unequal protein amounts, we incubated all membranes with α-Actin protein in a 1:3,000 
concentration after primary and secondary incubation with another specific antibody.  In this 
case we used α−mouse monoclonal HRP tagged antibody in a 1:3,000 concentration. 
 
Detection of Phosphorylated IRE.  In order to determine stress levels in MIN6 and Hela 
cells, we used α-Phospho IRE1 antibody in a 1:1,000 concentration.  The secondary antibody 
was α−rabbit polyclonal HRP tagged antibody.  
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Detection of Spliced XBP-1 mRNA 
Spliced XBP-1 mRNA was detected either by real time PCR or with normal PCR 
methods.   Using a 2.5 % agarose gel, and 5S (5’-TGGCCGGGTCTGCTGAGTCCG-3’) and 
10AS (5’-TCCATGGGAAGATGTTCTGG-3’) primers, splicing was detected by the presence 
of slightly smaller bands, whereas unspliced mRNA appears as a larger band.  This differential 
detection method is excellent to verify the presence of both spliced and unspliced mRNA.  For 
quantification of splicing, it was necessary to use real time PCR, with two different sets of 
primers.  For detection of spliced sequences, primers 11S(5’-TGAGTCCGAATCAGGTGCAG-
3’)-10AS provides a definitive detection method. Use of primers 
7S(5’CAGCACTCAGACTATGTGCA-3’)-10AS is sufficient to detect unspliced XBP-1 
mRNA.  
 
Drug Dosage Experiments 
In order to determine the optimum amount of AP20187 to use in our experiments we 
conducted a series of experiments using different dosages of the drug.  Final concentrations, 
when diluted in 10 mLs of media were as follows: 100 nM, 100 pM, 10 pM, and 1 pM.  All of 
these dilutions were made from a stock solution of 1 mM AP0187.  For our ATP dosage 
experiments, we used a dosage of 100 µM.  For stress induction in cells, we found that using 5 µl  
of tunicamycin was sufficient to elicit a satisfactory stress response. 
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RESULTS 
 
 
 
Developing an FV2E Construct 
Construction of FV2E-pCRIITOPO.  As previously stated, the fragment FV2E was 
developed with an overhang of HINDIII and NheI (Figure 4A) and then ligated into 
pCRIITOPO. The final construct of Fv2E-pCRIITOPO was a final size of 4.6 kb and contained 
the Fv2E fragment between the HINDIII and NheI sites (Figure 4B).  
 
Final Construction of Fv2E-Ire1β.  As mentioned before the expected results of ligations into 
pcDNA3 and pcDNA3.1/hygro were backwards.  In pcDNA3, the 5’ end of Fv2E-Ire1βPBS-SK 
should have ligated into the EcoRI site of pcDNA3 and the 3’ end into the XhoI site.  About 1.3 
kb downstream of this sequence sits the 0.6 kb FV2E fragment flanked by a 5’ HindIII site and a 
3’ NheI site.  The inserted fragment is located at the 3’ end of the of the N-Luminal domain.  
Following this insert, the structure of Ire1β is unadulterated and includes from 5’-3, the 
transmembrane domain, Kinase domain and the RNase domain (Figure 5).  As for ligation into 
pcDNA3.1/Hygro (-), the structure of the insert remains the same, except that the ligation of 
Fv2E Ire1β was accomplished using NotI (5’) and KpnI (3’).  Since this ligation was 
unsuccessful, however, we instead used a retrovirus expression system yielding successful 
incorporation of the FV2EIRE1β construct into the ER membrane of IRE1 knockout fibroblast 
cells.   
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Figure 5.  The Structure of the Final Functional Construct of FV2EIRE1β. 
A: Endogenous IRE1β contains an N-luminal domain (NLD) that participates in the stress sensing and dimerization 
capabilities of IRE.  Adjacent to the NLD is a transmembrane domain as well as a kinase domain which participates 
in trans-autophosphorylation.  IRE1’s RNase domain splices XBP1 mRNA in response to stress.  B: The construct 
“Fv2E-Ire1β,” is a modified form of IRE1β in which a small 46 bp fragment is removed from the N-Luminal 
domain (NLD) and replaced with the dimerization domain “Fv2E.”  This alteration of the NLD should not be 
enough to impede the NLD’s critical role in dimerization.  
 
Detection of XBP-1 in Stressed Cells 
In order to verify that our IRE1 knockout cell lines were in fact absent of all XBP-1 splicing 
we first tested these cell lines for XBP-1 splicing under stress.  In experiments using wild type 
and double knockout Ire1α and Ire1β fibroblast cell lines, we were able to detect XBP-1 splicing 
in stressed wild type cells.  XBP-1 splicing was detected in wild type but not knockout cells 
when cells were treated with cell stress activators thapsigargin (Tg) and tunicamycin (TM), two 
strong activators of ER stress (Figure 6). 
 
The Fv2EIRE1β System is a Stress Response Switch 
In order to verify that the receptor FV2E-IRE1β is a system that acts independently of 
cellular stress, our first experiments tested for expression of the transcription factor XBP-1 in 
FV2E fibroblast cells under various conditions.  Using western blot analysis we found that 
FV2EIRE1β can activate the cellular stress pathway that normally causes expression of XBP-1 
protein.  Also, since Tunicamycin causes XBP-1 expression in wild type cells we treated FV2E 
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cells with the drug and analyzed the lysates using western blotting analysis found that there is no 
XBP-1 expression, indicating that the receptor is controlled solely with AP20187 (Figure 7).   
 
Figure 6.  Detection of XBP-1 Splicing. 
IRE1 a and IRE1β wild type and knockout fibroblast cells were either untreated (UT), or treated to induce stress 
with 5 ml of thapsigargin (Tg), or 5 ml tunicamycin (TM).  Lysates were collected after 4 and 8 hours and RNA was 
isolated from these lysates.  After using reverse transcriptase PCR methods with primers specific for XBP-1 activity 
the samples were run on a 2.5% agarose gel. In wild type cells treated with TM and Tg, splicing was observed as the 
presence of two bands on the gel.  Only one band was observed in double knockout cell lines indicating that even 
under stress no XBP-1 splicing had occurred.   
 
 
 
Figure 7. Production of the Active Form of XBP-1 Transcription Factor by FV2E-IRE1β. 
Immunoblot of XBP-1 in lysates of IRE1 knockout cells expressing FV2E-IRE1β.  Cells were treated with either 
AP20187 or tunicamycin (TM) and lysates analyzed using western blotting with a-XBP-1 antibody.  Analysis of the 
results reveals that the FV2E-IRE1β system effectively uncouples XBP-1 production from stress and that the 
receptor can induce XBP-1 transcription factor production upon treatment with AP20187.  
 
Discovering Other Important Characteristics of the FV2E-IRE1/AP20187 System  
Although we have observed that tunicamycin treatment independent of AP20187 
treatment can not induce XBP-1 splicing, additional data demonstrates that FV2E-Ire1β activity 
is strongly enhanced when AP20187 treatment is combined with tunicamycin dosage.  The data 
gathered on the E3 ubiquitin ligase HRD1 displays conditions identical to those previously 
mentioned.  This data also shows that dosage with ATP does not enhance FV2E activation but 
may actually hinder it.  This could be a result of binding site competition from ATP.  In order to 
be sure that our system is not detrimental to cells, because Ire1 activation can induce ASK1 
leading to JNK induced apoptosis, we checked the levels of JNK expression in FV2E treated 
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cells.  Fortunately, AP20187 treatment does not cause JNK kinase induction in FV2E expressing 
cell lines (Figure 8).   
 
Figure 8.  Comprehensive Testing of the FV2E-IRE1β System.   
Immunoblot of lysates from IRE1 double knockout fibroblast cells transfected with FV2E-IRE1β.  Cells were 
treated were either left untreated, or treated for 5 hours with either ATP, AP20187, AP20187 and tunicamycin (TM), 
AP20187 and ATP, or AP20187, ATP, and TM.   Lysates were then checked for the presence of XBP-1 protein, 
HRD-1, and JNK, while actin was used as a loading control.  Although treatment with TM alone does not enhance 
levels of XBP-1 transcription factor production, the combination of AP20187 and TM greatly increases the 
efficiency of FV2E activation.  Production of XBP-1 protein is not, however, enhanced with ATP dosage alone or in 
combination with AP20187.  These characteristics are again observed in upregulation of HRD1.  Finally, treatment 
with AP20187 does not significantly induce activation of JNK kinase.  
 
The FV2E-Ire1β System is Time and Dosage Dependent 
In order to assure accuracy of results and optimal AP0187 performance, we tested various 
dosages of AP20187 on FV2E cells.  Our research shows that the system demonstrates the best 
results when the final concentration of AP20187 is 10 picomols (Figure 9B).  We postulate that 
the receptor reaches saturation at this concentration and we have also found that the best 
activation occurs with 2 hours of treatment (Figure 9A).  It should be noted, however, that 
receptor activation with AP20187 is not as strong as the endogenous stress response in wild type 
cells.  
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FV2E fibroblasts                  WT              IRE1α-/-
FV2E fibroblasts
A
B
 
 
Figure 9. FV2EIRE1β Exhibits Activation in a Time and Dosage Dependent Manner.   
A: Immunoblot of lysates from IRE1 double knockout fibroblast cells transfected with FV2E-IRE1β (FV2E 
fibroblasts) in comparison to wild type and knockout fibroblast cells.  FV2E fibroblast cells were either left 
untreated, or treated with AP20187 for 1, 2 and 5 hours.  Wild type and knockout cell lines were left untreated or 
treated with tunicamycin (TM) for 5 hours.  All lysates were then collected and analyzed using western blotting with 
a-XBP-1.  In FV2E fibroblasts, the best XBP-1 protein production was observed at 2 hours of AP20187 treatment 
but was not as strong as the wild type cell’s XBP-1 response to TM.  No XBP-1 transcription factor was produced in 
IRE1 α -/- cells. B:  To test for time dependency, FV2E fibroblasts were treated with AP20187 in concentrations of 
100 picomols (pM), 10 pM, and 1 pM.  Lysates were then collected and tested using western blotting with a-XBP1 
to determine at what concentration peak production of XBP-1 occurs.  Optimal XBP-1 transcription factor 
production occurs when cells are treated with 10 pM of AP20187.     
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DISCUSSION 
 
 
 Although much significant data has already been discovered in this research, there are 
still many important discoveries to be made using this receptor.  The most important factor in 
continuing the project was the discovery that using FV2E-IRE1β instead of endogenous Ire1 
uncouples IRE1 activity from cell stress.  Thus, XBP-1 splicing can be controlled solely using 
the inducer AP20187, and is independent of even the strongest stress.  This is beneficial as it 
gives the scientist complete control in eliciting an unconditional stress survival response.  
Additionally, because XBP-1 splicing is induced upon treatment with AP20187, HRD1 is also 
activated.  Activation of HRD1 is of paramount importance in rescuing cells from stress as it 
targets misfolded proteins for destruction through the ERAD response via the ubiquitin 
proteasome pathway.  Since our preliminary data shows that FV2EIRE1β activation does not 
significantly increase activation of the JNK “death kinase” we postulate that the system helps to 
mitigate cell death most likely through ERAD.  We postulate that normal activation of IRE1 may 
be transient because of the fluctuating amount of stress within the cell.  If the transient activation 
of IRE1 occurs in high frequency, JNK may be activated to deal with the stress.  When using 
AP20187, however, the activation of IRE1 is constant and controlled and thus does not send the 
cell into the JNK death pathway.  In order to test these conclusions, we plan to conduct apoptosis 
and cell viability assays using AP20187 under a variety of different stresses and time conditions. 
 Although we have successfully observed AP20187 stress-independent activation, XBP-1 
splicing, XBP-1 expression and HRD1 activation our data indicates that these responses are 
much stronger with the combination of tunicamycin and AP20187.  Based on this phenomenon, 
we hypothesize that there may be other signals important to the full activation of IRE1.  Our 
conclusion is that treatment with only AP20187 does in fact induce dimerization of FV2EIRE1β, 
but since no stress has caused the release of the chaperone BiP from its binding site on FV2E’s 
N-luminal domain, BiP may impede drug induced dimerization.  Treatment with tunicamycin, 
however, induces protein misfolding and thus releases BiP from the N-luminal domain to aide in 
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protein folding.  Consequently, we observe that induction of XBP-1 splicing and HRD1 activity 
drastically increases.  Concomitant with this activity, we also see minimal JNK kinase activity 
which indicates that small molecule induced dimerization of FV2EIRE1β is much more effective 
than stress induced dimerization of endogenous Ire1β and provides the cell with a method to 
bypass this death signal.  In addition to becoming familiar with these pathways in FV2EIRE1β 
implanted cells we would also like to develop a gene expression profile of all downstream targets 
of the receptor using DNA microarray analysis. 
 In an effort to further test our receptor, we would like to observe its activation in a cell 
line already under stress.  We have recently observed that mouse insulinoma cells (MIN6), a 
cancerous β-cell line, are already naturally under stress.  Because MIN6 cells meet both of the 
aforementioned requirements, we have recently created a stable MIN6 cell line expressing 
FV2EIRE1β.  This is a very important step since misfolded insulin in pancreatic β-cells may be 
responsible for misfolded insulin associated apoptosis in some forms of diabetes.  Furthermore, 
we hypothesize that the MIN6-FV2EIRE1β system will yield a good amount of high quality data 
since the receptor demonstrates peak efficiency under stress conditions. 
Following successful studies in MIN6 cells, we will create an animal model using the 
receptor in order to bring the research into a more clinical realm.  In animal studies we plan to 
create a vector system with a rat insulin promoter, which will target localization of the receptor 
in β-cells.  We will create a strain of mice that can be studied by mating a C57/B6 background 
mouse positive for the construct infection with an Akita diabetes model mouse.  This should 
produce, in one quarter of the offspring, an Fv2E:Akita/+ strain.  In this strain of mice we will 
leave half as untreated controls, and half will be treated with AP20187.  In theory, these diabetic 
Fv2E mice should display a vast improvement in diabetes and rescue from cell stress when 
treated with AP20187.  
With the development of this receptor, we hypothesize that we can successfully rescue 
pancreatic β-cells from stress caused by misfolded proteins.  Recently, Iwawaki et. al  has 
developed a fluorescence reporter system that helps monitor ER stress by fluorescing in the 
presence of spliced XBP-1.  The system is a fusion of the green fluorescent protein venus and the 
gene for XBP-1.  Upon XBP-1 splicing and resultant XBP-1 protein translation, fluorescence is 
emitted as an indicator of stress.  This system is of particular importance in our research as it can 
be transfected into a cell line that we are studying.  Once transfected the reporter and will yield 
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fast and accurate data about the level of XBP-1 splicing by fluorescence emission.  In the future, 
this system would be very effective in stress analysis and developing drug half lives. (Iwawaki et 
al, 2004).   
The relative importance of this system has been demonstrated with the development of 
another FV2E dimerization system.  The other FV2E based system, FV2E-PERK, was recently 
created by Lu et. al and successfully rescued cells from stress.  Much like our receptor, the 
system uses AP20187 to effect stress independent dimerization of a recombinant form of PERK 
containing two FV’ domains.  Dimerization of FV2E-PERK induced phosphorylation of eIF2α 
and caused suppression of general translation.  In suppressing general translation, cells were 
allowed the time to deal with and be successfully rescued from ER stress as well as oxidants and 
peroxynitrates (Lu et al, 2004). With further study and creation of animal models we should be 
able to show similar cytoprotective effects using FV2EIRE1β.         
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